feed
view company updates
tools
perform investment research
network
join events & discussions
banking
about us
SEARCH
ABOUT OUR MEMBERSHIPS
SIGN UP
LOG IN
Redeyes analytiker Oscar Bergman har tagit en pratstund med AroCells VD, Anders Hultman, gällande FDAs försening av utvärderingen för TK210 ELISA.
Oscar Bergman
Equity Analyst
By clicking "Sign up" you indicate that you read and agree to our Terms & Conditions